Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 418

1.

The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas.

Lin L, Miller CT, Contreras JI, Prescott MS, Dagenais SL, Wu R, Yee J, Orringer MB, Misek DE, Hanash SM, Glover TW, Beer DG.

Cancer Res. 2002 Sep 15;62(18):5273-9.

2.

Amplification and overexpression of the dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 (DYRK2) gene in esophageal and lung adenocarcinomas.

Miller CT, Aggarwal S, Lin TK, Dagenais SL, Contreras JI, Orringer MB, Glover TW, Beer DG, Lin L.

Cancer Res. 2003 Jul 15;63(14):4136-43.

4.

Identification and characterization of a 19q12 amplicon in esophageal adenocarcinomas reveals cyclin E as the best candidate gene for this amplicon.

Lin L, Prescott MS, Zhu Z, Singh P, Chun SY, Kuick RD, Hanash SM, Orringer MB, Glover TW, Beer DG.

Cancer Res. 2000 Dec 15;60(24):7021-7.

5.

Identification of putative oncogenes in lung adenocarcinoma by a comprehensive functional genomic approach.

Li R, Wang H, Bekele BN, Yin Z, Caraway NP, Katz RL, Stass SA, Jiang F.

Oncogene. 2006 Apr 27;25(18):2628-35.

PMID:
16369491
6.

Gene amplification in esophageal adenocarcinomas and Barrett's with high-grade dysplasia.

Miller CT, Moy JR, Lin L, Schipper M, Normolle D, Brenner DE, Iannettoni MD, Orringer MB, Beer DG.

Clin Cancer Res. 2003 Oct 15;9(13):4819-25.

7.

Transcriptional oncogenomic hot spots in Barrett's adenocarcinomas: serial analysis of gene expression.

Razvi MH, Peng D, Dar AA, Powell SM, Frierson HF Jr, Moskaluk CA, Washington K, El-Rifai W.

Genes Chromosomes Cancer. 2007 Oct;46(10):914-28.

PMID:
17636545
8.

ERBB2 amplifications in esophageal adenocarcinoma.

Dahlberg PS, Jacobson BA, Dahal G, Fink JM, Kratzke RA, Maddaus MA, Ferrin LJ.

Ann Thorac Surg. 2004 Nov;78(5):1790-800.

PMID:
15511476
9.

Molecular dissection of 17q12 amplicon in upper gastrointestinal adenocarcinomas.

Maqani N, Belkhiri A, Moskaluk C, Knuutila S, Dar AA, El-Rifai W.

Mol Cancer Res. 2006 Jul;4(7):449-55.

10.

Gene amplification in gastric and esophageal adenocarcinomas.

Houldsworth J, Cordon-Cardo C, Ladanyi M, Kelsen DP, Chaganti RS.

Cancer Res. 1990 Oct 1;50(19):6417-22.

11.

BCL2L2 is a probable target for novel 14q11.2 amplification detected in a non-small cell lung cancer cell line.

Kawasaki T, Yokoi S, Tsuda H, Izumi H, Kozaki K, Aida S, Ozeki Y, Yoshizawa Y, Imoto I, Inazawa J.

Cancer Sci. 2007 Jul;98(7):1070-7. Epub 2007 Apr 24.

12.

Identification of a novel gene, GASC1, within an amplicon at 9p23-24 frequently detected in esophageal cancer cell lines.

Yang ZQ, Imoto I, Fukuda Y, Pimkhaokham A, Shimada Y, Imamura M, Sugano S, Nakamura Y, Inazawa J.

Cancer Res. 2000 Sep 1;60(17):4735-9.

13.

Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster.

Bai C, Connolly B, Metzker ML, Hilliard CA, Liu X, Sandig V, Soderman A, Galloway SM, Liu Q, Austin CP, Caskey CT.

Proc Natl Acad Sci U S A. 2000 Feb 1;97(3):1230-5.

14.

Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma.

Zatkova A, Rouillard JM, Hartmann W, Lamb BJ, Kuick R, Eckart M, von Schweinitz D, Koch A, Fonatsch C, Pietsch T, Hanash SM, Wimmer K.

Genes Chromosomes Cancer. 2004 Feb;39(2):126-37.

PMID:
14695992
15.

Comprehensive characterization of the DNA amplification at 13q34 in human breast cancer reveals TFDP1 and CUL4A as likely candidate target genes.

Melchor L, Saucedo-Cuevas LP, Muñoz-Repeto I, Rodríguez-Pinilla SM, Honrado E, Campoverde A, Palacios J, Nathanson KL, García MJ, Benítez J.

Breast Cancer Res. 2009;11(6):R86. doi: 10.1186/bcr2456. Epub 2009 Dec 8.

16.

Melanoma-associated antigens in esophageal adenocarcinoma: identification of novel MAGE-A10 splice variants.

Lin J, Lin L, Thomas DG, Greenson JK, Giordano TJ, Robinson GS, Barve RA, Weishaar FA, Taylor JM, Orringer MB, Beer DG.

Clin Cancer Res. 2004 Sep 1;10(17):5708-16.

17.

High frequency of simultaneous loss of p16 and p16beta gene expression in squamous cell carcinoma of the esophagus but not in adenocarcinoma of the esophagus or stomach.

Hayashi K, Metzger R, Salonga D, Danenberg K, Leichman LP, Fink U, Sendler A, Kelsen D, Schwartz GK, Groshen S, Lenz HJ, Danenberg PV.

Oncogene. 1997 Sep 18;15(12):1481-8.

19.

Identification of target genes within an amplicon at 14q12-q13 in esophageal squamous cell carcinoma.

Yasui K, Imoto I, Fukuda Y, Pimkhaokham A, Yang ZQ, Naruto T, Shimada Y, Nakamura Y, Inazawa J.

Genes Chromosomes Cancer. 2001 Oct;32(2):112-8.

PMID:
11550278
20.

Role of amplified genes in the production of autoantibodies.

Brass N, Rácz A, Bauer C, Heckel D, Sybrecht G, Meese E.

Blood. 1999 Apr 1;93(7):2158-66.

Supplemental Content

Support Center